Multithread effectively and personalize outreach to convert deals faster
Elevate social presence and drive business growth from social media
Identify and prioritize high-intent leads, and improve sales effectiveness
Find and connect with ICP attendees, and improve event outcomes
Seer, Inc. is a life sciences company focused on transforming biology and healthcare by providing a new window into the proteome. They develop and commercialize the Proteographâ„¢ Product Suite, an integrated solution consisting of consumables, an automation instrument, and software, designed to enable deep, unbiased, and rapid proteomic analysis at scale. Seer's technology utilizes proprietary engineered nanoparticles to selectively capture and enrich proteins from complex biological samples, empowering researchers to make new discoveries in areas like disease biomarker identification, drug development, and precision medicine.
The headquarters serves as the primary center for Seer's corporate leadership, research and development (R&D), product innovation, manufacturing oversight, and administrative operations. It's the hub for strategic planning and the development of their proteomics platform.
The facility likely includes state-of-the-art laboratory spaces equipped for advanced proteomics research, clean rooms for nanoparticle and consumable manufacturing processes, and collaborative workspaces designed to foster innovation. Specific architectural details are not widely publicized.
Seer's work culture is characterized by a strong emphasis on scientific innovation, collaboration, and a fast-paced environment typical of a growth-stage biotechnology company. Employees are driven by the mission to advance proteomic understanding and its applications in human health.
Its location in Redwood City provides Seer with strategic advantages, including access to a rich talent pool from nearby universities and research institutions, proximity to venture capital, and opportunities for collaboration within the dense biotech network of the Bay Area.
Seer, Inc. focuses on the global life sciences market. While its primary operations and headquarters are in Redwood City, California, the company's Proteographâ„¢ Product Suite is available to researchers and institutions in North America, Europe, and parts of Asia-Pacific. Their global reach is facilitated through direct sales and support teams, and potentially through distribution partnerships in key international markets. Operations are largely centralized, with field personnel supporting global customers.
3800 Bridge Parkway, Suite 102
Redwood City
CA
USA
No additional office locations available.
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
As of April 2025, Seer' leadership includes:
Seer has been backed by several prominent investors over the years, including:
In the past 12-15 months, Seer, Inc. strengthened its leadership by appointing a new Chief Operating Officer and a new Chief Medical Officer, while also seeing the departure of its Chief Business Officer. These changes reflect the company's ongoing evolution and focus on operational scaling and clinical strategy.
Discover the tools Seer uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
Seer, Inc. likely uses standard corporate email address formats. Common patterns include [first_initial][last]@seer.bio or [first].[last]@seer.bio. For example, an employee named Jane Doe might have an email address like jdoe@seer.bio or jane.doe@seer.bio.
[first].[last]@seer.bio or [first_initial][last]@seer.bio
Format
jane.doe@seer.bio
Example
75%
Success rate
Seer, Inc. Investor Relations • February 28, 2024
Seer reported its financial results for the fourth quarter and full year ended December 31, 2023, discussing revenue, operational highlights, and strategic outlook for its Proteograph Product Suite....more
Seer, Inc. Investor Relations • February 06, 2024
Seer showcased new data at the Advances in Genome Biology and Technology (AGBT) General Meeting, highlighting the capabilities of its Proteograph Product Suite for deep, unbiased proteomic insights....more
Seer, Inc. Investor Relations • October 02, 2023
Seer announced the appointment of Scott M. Tibbitts as its Chief Operating Officer, leveraging his extensive experience in the life sciences industry to scale operations and manufacturing....more
See where a company’s workforce is located, by country or region.
View past and recent funding rounds with amounts and investors.
Understand company revenue estimates and financial scale.
Track active roles and hiring trends to spot growth signals.
Discover what a company offers—products, platforms, and solutions.
Get the company’s official SIC and NAICS classifications.
Analyze visitor volume, engagement, and top traffic sources.
Explore LinkedIn, Twitter, and other active social profiles.
Identify top competitors based on similar business traits.
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
Thousands of companies, including Seer, are just a search away.